SCHEMBL8711615

SCHEMBL8711615

CC(C)N1c2ccccc2Sc2cc(CO)ccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.45
PTGS2 P35354 2/20 0.45
BCHE P06276 7/20 0.41
ADRA2A P08913 2/20 0.41
ADRA2B P18089 2/20 0.41
ADRA2C P18825 2/20 0.41
CHRM3 P20309 2/20 0.41
SLC6A2 P23975 2/20 0.41
HTR2C P28335 2/20 0.41
SLC6A4 P31645 2/20 0.41
DRD3 P35462 2/20 0.41
HTR2B P41595 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NOX1 Q9Y5S8 1/20 0.41
CYP2D6 P10635 4/20 0.40
LMNA P02545 2/20 0.40
CYP1A2 P05177 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7125071 0.83 MAOA (0.61) PTGS1PTGS2BCHEADRA2AADRA2B
SCHEMBL8715308 0.81 PTGS1 (0.46) PTGS1PTGS2BCHEADRA2AADRA2B
SCHEMBL30184394 0.80 MAOA (0.58) PTGS1PTGS2BCHEADRA2AADRA2B
SCHEMBL627482 0.80 MAOA (0.58) PTGS1PTGS2BCHEADRA2AADRA2B
SCHEMBL10052735 0.79 CYP2D6 (0.72) PTGS1PTGS2BCHEADRA2AADRA2B
SCHEMBL25842306 0.78 KDM1A (0.48) PTGS1PTGS2ADRA2AADRA2BADRA2C
SCHEMBL8714035 0.76 KDM1A (0.56) ADRA2AADRA2BADRA2CCHRM3SLC6A2
SCHEMBL28045484 0.75 NOX1 (0.59) PTGS2BCHEADRA2AADRA2BADRA2C
SCHEMBL20760007 0.74 NOX1 (0.46) ADRA2AADRA2BADRA2CCHRM3SLC6A2
SCHEMBL8711321 0.73 BCHE (0.41) PTGS1PTGS2BCHEADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5830902-A SQUALENE SYNTHASE INHIBITOR YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-11-03 US disclosed
CN-1177353-A Novel quinuclidine derivatives having tricyclic fused hereto ring YAMANOUCHI PHARMA CO LTD (JP) 1998-03-25 CN disclosed
EP-0812840-A1 NOVEL QUINUCLIDINE DERIVATIVES HAVING TRICYCLIC FUSED HETERO RING YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1997-12-17 EP disclosed